News

FDA approves med tech innovation with University of Iowa roots

Wednesday, February 14, 2024
Boston Scientific Corporation received FDA approval for the Farapulse™ Pulsed Field Ablation (PFA) System, a simple, cost-effective alternative to the standard-of-care thermal ablation treatment. University of Iowa startup Farapulse, Inc. (originally Iowa Approach), developed the technology before medical device corporation Boston Scientific acquired the company in June 2021. Farapulse was founded by Dr. Steven Mickelsen in the Carver College of Medicine.

Emmyon and Virbac identify a new nutritional approach that helps maintain healthy skeletal muscle and activity in dogs

Friday, January 26, 2024
Emmyon, a start-up company founded by Dr. Christopher Adams during his tenure at the University of Iowa, has announced the publication of an important new study conducted in collaboration with Virbac Corporation, an international leader in nutritional and pharmaceutical products for animal health.

Five tools to take your research to the next level in the new year

Thursday, January 25, 2024
Explore the resources available through the Office of the Vice President for Research to help researchers, scholars, and creators across our campus achieve their research goals.

Cardio Diagnostics Holdings, Inc. Announces the Grant of a Patent in India

Tuesday, January 16, 2024
Cardio Diagnostics Holdings, Inc. a pioneering AI-driven precision cardiovascular medicine company by UI faculty Dr. Robert Philibert and UI graduate Dr. Meesha Dogan, today announced that India’s Patent Office has granted a patent to the University of Iowa Research Foundation titled “A Kit for Determining Methylation Status of a CpG Dinucleotide and a Genotype of a Single Nucleotide Polymorphism."

Lantheus Expands Radiopharmaceutical Oncology Pipeline via Strategic Agreements with Perspective Therapeutics

Tuesday, January 16, 2024
Lantheus Holdings, Inc. today announced it has entered into multiple strategic agreements with Perspective Therapeutics, Inc., co-founded by UI Professor Mark Schultz and Dr. Frances Johnson, a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body.

Salem named a Fellow of the National Academy of Inventors.

Wednesday, December 13, 2023
Lyle and Sharon Bighley Chair and Professor Aliasger Salem has been named a Fellow of the National Academy of Inventors (NAI). Election as an Academy Fellow is the highest professional distinction awarded solely to inventors.

Upcoming deadline for Iowa JPEC Innovation Challenge Fall 2023

Tuesday, October 24, 2023
The Innovation Challenge will bring $225,000 in total funding during the 2023-24 academic year across the University of Iowa's campus. The Challenge is a university-wide competition with the goal to identify, advance and support the most innovative and entrepreneurial projects on campus.

IIHR Innovation Day

Tuesday, September 26, 2023
Please join UIRF at the upcoming innovation day, October 10th, at the Stanley Hydraulics Lab. Agenda includes educational sessions on intellectual property and information for graduate students and post-docs. Lunch provided!

2024 Equalize pitch competition.

Established in 2020, Equalize is a comprehensive program designed to take national action around the disparity of women academic inventors forming university startups. Equalize participants receive education, a field-specific mentor, and access to networks that drive new entrepreneurial connections. If you would like to participate or have any questions, please feel free to reach out to a licensing associate.

hC Bioscience Moves to Boston's Seaport as Part of its Commitment to Employees and Innovation

Wednesday, July 12, 2023
hC Bioscience, co-founded by UI Faculty Dr. Chrisopher Ahern, has moved and consolidated its team to a new biotech-dedicated facility located in Boston's Seaport. The office, situated at 645 Summer Street, Suite 102, will serve as an important hub for hC Bioscience's continued growth and innovation in the field of tRNA.